↓ Skip to main content

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

Overview of attention for article published in Trials, August 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
18 Mendeley